NO20024108D0 - Oralt administrert kontrollert leveringssystem for þn daglig administrering av ciprofloxacin - Google Patents

Oralt administrert kontrollert leveringssystem for þn daglig administrering av ciprofloxacin

Info

Publication number
NO20024108D0
NO20024108D0 NO20024108A NO20024108A NO20024108D0 NO 20024108 D0 NO20024108 D0 NO 20024108D0 NO 20024108 A NO20024108 A NO 20024108A NO 20024108 A NO20024108 A NO 20024108A NO 20024108 D0 NO20024108 D0 NO 20024108D0
Authority
NO
Norway
Prior art keywords
ciprofloxacin
delivery system
orally administered
daily administration
controlled delivery
Prior art date
Application number
NO20024108A
Other languages
English (en)
Other versions
NO20024108L (no
Inventor
Naresh Talwar
John Nicholas Staniforth
Ashok Rampal
Gour Mukherji
Badri N Vishwanathan
Brij Khera
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of NO20024108D0 publication Critical patent/NO20024108D0/no
Publication of NO20024108L publication Critical patent/NO20024108L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20024108A 2000-03-03 2002-08-28 Oralt administrert kontrollert leveringssystem for en daglig administrering av ciprofloksasin NO20024108L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (2)

Publication Number Publication Date
NO20024108D0 true NO20024108D0 (no) 2002-08-28
NO20024108L NO20024108L (no) 2002-10-25

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024108A NO20024108L (no) 2000-03-03 2002-08-28 Oralt administrert kontrollert leveringssystem for en daglig administrering av ciprofloksasin

Country Status (31)

Country Link
EP (1) EP1263409A1 (no)
JP (1) JP2003525229A (no)
KR (1) KR20030009374A (no)
CN (1) CN1420763A (no)
AP (2) AP1485A (no)
AR (1) AR032614A1 (no)
AU (1) AU3589701A (no)
BG (1) BG107055A (no)
BR (1) BR0108958A (no)
CA (1) CA2400950A1 (no)
CZ (1) CZ20022883A3 (no)
DO (1) DOP2001000130A (no)
EA (1) EA200200914A1 (no)
EC (1) ECSP013952A (no)
EE (1) EE200200497A (no)
GT (1) GT200100033A (no)
HN (1) HN2001000038A (no)
HR (1) HRP20020715A2 (no)
HU (1) HUP0204417A3 (no)
IL (1) IL151553A0 (no)
IS (1) IS6532A (no)
MX (1) MXPA02008568A (no)
NO (1) NO20024108L (no)
NZ (1) NZ520927A (no)
OA (1) OA12381A (no)
PE (1) PE20011113A1 (no)
PL (1) PL365071A1 (no)
SK (1) SK12542002A3 (no)
WO (1) WO2001064183A1 (no)
YU (1) YU66202A (no)
ZA (1) ZA200206764B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
WO2017143438A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
EE200100153A (et) * 1998-09-14 2002-06-17 Ranbaxy Laboratories Limited Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Also Published As

Publication number Publication date
EP1263409A1 (en) 2002-12-11
PL365071A1 (en) 2004-12-27
YU66202A (sh) 2005-09-19
KR20030009374A (ko) 2003-01-29
NO20024108L (no) 2002-10-25
ZA200206764B (en) 2003-03-04
BR0108958A (pt) 2003-09-30
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
CA2400950A1 (en) 2001-09-07
JP2003525229A (ja) 2003-08-26
ECSP013952A (es) 2002-04-23
HUP0204417A3 (en) 2005-03-29
CZ20022883A3 (cs) 2003-04-16
CN1420763A (zh) 2003-05-28
AP1485A (en) 2005-10-31
IS6532A (is) 2002-08-28
AP2002002627A0 (en) 2002-09-30
BG107055A (bg) 2003-06-30
AP2001002084A0 (en) 2001-03-31
MXPA02008568A (es) 2003-02-24
HN2001000038A (es) 2005-03-23
IL151553A0 (en) 2003-04-10
OA12381A (en) 2004-09-06
AR032614A1 (es) 2003-11-19
PE20011113A1 (es) 2001-10-14
SK12542002A3 (sk) 2003-05-02
HRP20020715A2 (en) 2004-12-31
DOP2001000130A (es) 2004-03-31
NZ520927A (en) 2003-06-30
EA200200914A1 (ru) 2003-02-27
WO2001064183A1 (en) 2001-09-07
EE200200497A (et) 2004-02-16
AU3589701A (en) 2001-09-12

Similar Documents

Publication Publication Date Title
NO20014035D0 (no) System for oral administrasjon av medikament
NO20020976L (no) Retarderte, orale, farmasöytiske administreringsformer
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
EE200200349A (et) Antiprogestiinsete omadustega ravimite manustamise vahendid
NO20033343L (no) Farmasöytiske doseringsformer av epothiloner for oral administrasjon
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
NO20004823L (no) Nye galeniske formuleringer av meloksicam for oral administrering
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
ITRM20010226A1 (it) Dispositivo impiantabile di altezza ridotta per la somministrazione di preparati medicinali.
NO20024108D0 (no) Oralt administrert kontrollert leveringssystem for þn daglig administrering av ciprofloxacin
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO20026212D0 (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
MA27689A1 (fr) Forme galenique orale pour la liberation controlee de medicament
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering
FR2861992B1 (fr) Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi